Citalopram ist das am häufigsten verordnete Antidepressivum in Deutschland – rund eine Million Menschen nehmen es täglich. Es gehört zur Klasse der selektiven Serotonin-Wiederaufnahmehemmer (SSRI) und wird vor allem bei Depressionen und Angststörungen eingesetzt.

This article is for informational purposes and does not replace psychiatric advice. Never stop citalopram or change the dose on your own. For suicidal thoughts: Samaritans 116 123 (free, 24/7).
Citalopram belongs to the group of selective serotonin reuptake inhibitors (SSRIs) and is one of the most widely prescribed antidepressants. It is used for depression, panic disorder, and anxiety disorders. One important feature: citalopram prolongs the QT interval on the ECG in a dose-dependent manner — which makes regular cardiac monitoring necessary and limits the maximum dose to 40 mg.
| Property | Details |
|---|---|
| Active substance | Citalopram (as citalopram hydrobromide) |
| ATC code | N06AB04 |
| Drug class | Selective serotonin reuptake inhibitor (SSRI) |
| Available forms | Tablets 10 mg, 20 mg, 40 mg; oral drops |
| Half-life | approx. 36 hours |
| Onset of action | Increased drive after 1–2 weeks; mood improvement after 2–4 weeks |
| Bioavailability | approx. 80% |
| Intake | Once daily, independent of meals |
| Maximum dose | 40 mg/day (20 mg in over-65s, hepatic impairment, CYP2C19 poor metabolisers) |
| Prescription only | Yes |
| Special feature | Dose-dependent QT prolongation! ECG recommended. |
To understand how citalopram works, it helps to look at the brain: nerve cells communicate via messenger substances released into the synaptic cleft. After signal transmission, these messenger substances are normally taken back up by the releasing nerve cell — a process called reuptake. Serotonin is one such messenger substance that is often at too low a concentration in depression and anxiety disorders.
Citalopram selectively blocks the serotonin transporter (SERT) — the protein responsible for serotonin reuptake. With the transporter blocked, serotonin remains in the synaptic cleft longer and can stimulate the downstream receptors for longer. The result: increased serotonin activity in the brain.
This is the question that almost all patients have at the start of therapy. The pharmacological answer is interesting: the increase in serotonin in the synaptic cleft occurs immediately — the SERT is blocked after the very first tablet. But the actual antidepressant effect only develops through an adjustment (desensitisation) of the receptors. The brain initially responds to the persistently elevated serotonin with a counter-regulation — it reduces the sensitivity of its own receptors. Only when this adjustment is complete does the full therapeutic effect emerge. This takes 2–4 weeks.
During this adjustment period, side effects can even intensify while the antidepressant effect has not yet appeared. This is medically normal and not a sign that the medication isn't working. Important: anyone who develops suicidal thoughts during this phase must contact their doctor immediately or call the Samaritans (116 123, free, 24/7).
Citalopram consists chemically of two mirror-image molecules: the S-enantiomer and the R-enantiomer. In pharmacology this is called a racemate. The antidepressant effect comes almost entirely from the S-enantiomer. The R-enantiomer contributes little to the effect but is partly responsible for the QT prolongation. For this reason, the pure S-enantiomer was developed as an independent active substance: escitalopram — equivalent antidepressant effect, half the dose, slightly lower QT risk.
Citalopram is used for various mental health conditions, with depression and panic disorder as the main indications. A fundamental principle applies to all indications: start low, increase slowly. A low starting dose of 10 mg in the first week is especially important for panic disorder — too rapid a dose increase can initially intensify anxiety.
| Indication | Starting dose | Target dose | Maximum dose |
|---|---|---|---|
| Depression | 20 mg | 20–40 mg | 40 mg (20 mg in older adults) |
| Panic disorder | 10 mg (week 1) | 20–40 mg | 40 mg |
| Generalised anxiety disorder | 10–20 mg | 20–40 mg | 40 mg (off-label) |
| OCD | 20 mg | 20–40 mg | 40 mg (off-label) |
| Older patients (>65) | 10 mg | 10–20 mg | 20 mg! |
| Hepatic impairment | 10 mg | 10–20 mg | 20 mg! |
Citalopram's side effects follow a typical pattern over time that patients should be aware of — because knowing what to expect makes it easier to cope and prevents therapy being abandoned prematurely.
In the first 1–2 weeks, adjustment reactions predominate. Nausea is the most common complaint — affecting over 10% of patients — and resolves for most after 1–2 weeks on its own. Headaches, sleep disturbances, and inner restlessness are also common. An important warning: in the first few weeks, drive and energy can increase before mood improvement sets in. In patients with suicidal thoughts, this can temporarily increase risk — close contact with the doctor during this phase is essential.
From the second week, mood improvement typically begins. Nausea subsides. At this point it becomes clear whether the dose is adequate or needs adjusting — a doctor's appointment during this phase is advisable. Anyone who notices no improvement after 4–6 weeks should discuss a dose adjustment or switch with their doctor.
The most commonly underestimated long-term side effects are sexual dysfunction and emotional blunting. Sexual side effects — reduced libido, difficulty achieving orgasm, erectile dysfunction — affect 40–70% of patients according to studies. They are frequently not raised because the subject is uncomfortable. Yet there are options: dose reduction, switching to bupropion or mirtazapine, or a so-called "drug holiday" at the weekend — all of this should be openly discussed with the doctor.
Emotional blunting — the feeling of no longer really feeling anything, neither joy nor sadness — is another common long-term complaint. Some patients find it worse than the original depression. Here too: raise it, don't stay silent. Sometimes a dose reduction is enough; sometimes switching to a different active substance is the better solution.
| Side effect | Frequency | Note |
|---|---|---|
| Nausea | Very common (>10%) | Usually in weeks 1–2, then improves |
| Dry mouth | Common | Drink plenty of water; sugar-free sweets |
| Sweating | Common | Especially at night — often persistent |
| Sleep disturbances / fatigue | Common | Adjust intake time (morning vs. evening) |
| Sexual dysfunction | Very common (40–70%) | Reduced libido, difficulty with orgasm, erectile dysfunction. Raise with doctor! |
| Weight gain | Common | Average 2–5 kg over 6–12 months |
| Emotional blunting | Common | Feeling nothing properly any more. Raise with doctor! |
| QT prolongation | Dose-dependent | ECG monitoring, especially above 20 mg |
| Increased bleeding risk | Class effect | Serotonin in platelets reduced by up to 80% |
| Brain zaps (on discontinuation) | Common | Brief electrical shock sensations — typical discontinuation symptom |
Stopping citalopram is for many patients the most difficult phase of the entire treatment. Up to 56% of patients develop symptoms on discontinuation — ranging from mild to severe. This is not because citalopram is "addictive" but due to physiology: the brain has adapted over months to elevated serotonin levels and reacts to sudden withdrawal with a counter-response.
Brain zaps are the most widely known and unsettling discontinuation symptom: a brief electrical shock sensation in the head, often triggered by eye movements. They occur because serotonin receptors recalibrate on discontinuation and temporarily over-react in the process. Brain zaps are unpleasant but not dangerous — and they disappear if the taper is slow enough.
The most important principle: the more slowly you taper, the milder the symptoms. Patients who stop abruptly risk severe discontinuation syndromes. Patients who reduce gradually over weeks and months can often discontinue symptom-free.
This has a pharmacological explanation: the serotonin transporter blockade does not behave linearly with dose. At 20 mg, over 80% of transporters are already blocked. At 10 mg, approximately 70% are blocked. But when reducing from 10 mg to 5 mg, the blockade falls more sharply — and the brain notices the change more intensely than when reducing from 40 to 30 mg. This explains why the last milligrams are the hardest. Oral drops allow particularly fine dosage steps and are very valuable during this phase.
| Discontinuation symptom | Description | Duration |
|---|---|---|
| Brain zaps | Brief electrical shock sensations in the head, often triggered by eye movement | Days to weeks |
| Dizziness | Sometimes severe enough to make getting up difficult | Days to weeks |
| Irritability / mood swings | Often confused with a relapse of depression! | Days to months |
| Flu-like symptoms | Aching limbs, sweating, chills | Days |
| Nausea / diarrhoea | Gastrointestinal symptoms | Days |
| Sleep disturbances / vivid dreams | Very vivid, intense dreams | Weeks |
| Paraesthesia | Tingling, numbness in hands and feet | Days to weeks |
| Phase | Dose | Duration | Note |
|---|---|---|---|
| Phase 1 | 40 mg → 30 mg | 2 weeks | Use drops for precise dosing |
| Phase 2 | 30 mg → 20 mg | 2 weeks | – |
| Phase 3 | 20 mg → 15 mg | 2 weeks | Symptoms often first appear here |
| Phase 4 | 15 mg → 10 mg | 2 weeks | – |
| Phase 5 | 10 mg → 5 mg | 2–4 weeks | Most critical phase! Reduce very slowly |
| Phase 6 | 5 mg → stop | 1–2 weeks | Alternative: 5 mg every other day |
| Phase | Dose | Duration |
|---|---|---|
| Phase 1 | 20 mg → 15 mg | 2 weeks |
| Phase 2 | 15 mg → 10 mg | 2 weeks |
| Phase 3 | 10 mg → 5 mg | 2–4 weeks |
| Phase 4 | 5 mg → stop | 1–2 weeks |
This combination is alarmingly common: patients take citalopram daily — and reach for an ibuprofen tablet from the medicine cabinet for headaches, back pain, or joint pain. Without knowing they are taking on a massive bleeding risk. brite's interaction check detects this combination automatically.
| Painkiller | Risk with citalopram | Recommendation |
|---|---|---|
| Ibuprofen / diclofenac | 12-fold increased GI bleeding risk | Avoid! If unavoidable: short-term only + pantoprazole |
| Aspirin 75–100 mg (blood thinning) | 5-fold increased bleeding risk | Only with compelling indication + pantoprazole |
| Paracetamol (acetaminophen) | No increased bleeding risk | First choice for pain relief under SSRI |
| Metamizole (dipyrone) | No increased bleeding risk | Alternative — but has its own risks (agranulocytosis) |
The rule is easy to remember: anyone taking citalopram or another SSRI should use paracetamol (acetaminophen) as their standard painkiller and only use ibuprofen in exceptional circumstances and always with stomach protection. Keep this information available for all treating doctors — not every doctor who prescribes a painkiller will know you are also taking an SSRI. Maintain a complete medication list.
The QT interval is a measure of the electrical recovery phase of the heart on the ECG. When this phase is prolonged, a dangerous cardiac arrhythmia called torsades de pointes can occur — appearing without warning and potentially fatal. Citalopram prolongs the QT interval in a dose-dependent manner and has the strongest QT risk among all SSRIs. This is the main reason for the dose limit of 40 mg — and why an ECG before and during therapy is important.
Older patients over 65 have a higher baseline risk for QT prolongation and must therefore receive a maximum of 20 mg citalopram daily. Patients with known long QT syndrome must not take citalopram at all. Particularly insidious: electrolyte disturbances — especially low potassium or magnesium levels — also increase QT risk. Diuretics lower potassium levels; pantoprazole lowers magnesium levels with long-term use. Anyone taking citalopram together with a diuretic or PPI therefore has a doubly elevated risk and should have electrolytes checked regularly.
Citalopram has some clinically very significant interactions, two of which are absolutely contraindicated: combination with MAO inhibitors and with St John's wort. Both can trigger serotonin syndrome — a potentially life-threatening over-activation of the serotonin system with symptoms including confusion, muscle tremor, palpitations, and fever. Check all your combinations with the interaction check.
| Substance / medication | Interaction | Recommendation |
|---|---|---|
| MAO inhibitors (tranylcypromine, moclobemide) | Serotonin syndrome (life-threatening!) | CONTRAINDICATED! 14-day gap after irreversible MAO inhibitor |
| Ibuprofen / diclofenac / aspirin | 12-fold increased GI bleeding risk | Avoid! Prefer paracetamol (acetaminophen) |
| Tramadol, triptans | Serotonin syndrome risk | Only under medical supervision |
| St John's wort | Serotonin syndrome + enhanced effect | CONTRAINDICATED! Never combine on your own |
| QT-prolonging agents (amiodarone, haloperidol, pimozide) | Additive QT prolongation → torsades de pointes | Contraindicated or only with ECG monitoring |
| Lithium | Enhanced serotonin effect + altered levels | Monitor lithium levels |
| Omeprazole / esomeprazole | CYP2C19 inhibition → citalopram levels rise | Maximum citalopram 20 mg. Pantoprazole is the safer choice |
| Alcohol | Enhances CNS-depressant effect | Restrict — worsens depressive symptoms |
| Warfarin / anticoagulants | Increased bleeding risk | Monitor INR |
A frequently overlooked risk: the combination citalopram + omeprazole. Omeprazole inhibits the liver enzyme CYP2C19, which breaks down citalopram. This raises citalopram blood levels — with correspondingly increased QT risk. Anyone who needs stomach protection should choose pantoprazole instead of omeprazole, as pantoprazole barely inhibits CYP2C19.
All three are SSRIs — but with different profiles that are relevant for certain patient groups. The choice between them is made by the doctor, but a basic understanding of the differences helps patients have a more informed conversation.
| Property | Citalopram | Escitalopram | Sertraline |
|---|---|---|---|
| Drug class | SSRI (racemate) | SSRI (pure S-enantiomer) | SSRI |
| Standard dose | 20 mg | 10 mg | 50–100 mg |
| QT prolongation | Yes — strongest among SSRIs! | Yes — less than citalopram | Minimal |
| Max dose in older adults | 20 mg | 10 mg | 200 mg |
| Discontinuation symptoms | Moderate (half-life 36h) | Moderate (half-life 30h) | Mild–moderate (half-life 26h) |
| Breastfeeding | Possible | Possible | Preferred (lowest transfer) |
| Price (30 days) | £2–4 | £3–5 | £3–5 |
Escitalopram is increasingly preferred because it is the pure active enantiomer of citalopram — equivalent antidepressant effect at half the dose and with slightly lower QT risk. For patients with cardiac risk factors, escitalopram is therefore the better choice. For stably maintained citalopram patients, a switch is usually not necessary.
The evidence base for citalopram in pregnancy is nuanced. The medication crosses the placenta. There is no clear evidence of malformations in humans, but newborns may show adaptation symptoms: tremor, feeding difficulties, irritability — symptoms that typically resolve within days. Important: abruptly stopping during pregnancy is also risky, as a relapse of depression can be harmful to both mother and baby. Every decision should be made individually with the psychiatrist and obstetrician — the UK Teratology Information Service (UKTIS) provides current information.
Citalopram passes into breast milk. Sertraline is considered the SSRI with the lowest transfer into breast milk and is frequently preferred during breastfeeding. The decision must always be made individually with the doctor.
The brite app shows a clear pattern among citalopram users: information gaps around interactions and discontinuation are the most common problems — and both are dangerous.
| Observation | Frequency | Typical comment |
|---|---|---|
| Ibuprofen combination not recognised as a risk | Very common | "The app warned me not to take ibuprofen. I didn't know that." |
| Stopping without tapering on own initiative | Very common | "I just stopped — then the brain zaps started." |
| Sexual side effects never raised | Common | "I never dared to ask my doctor about it." |
| Weight gain frustrating | Common | "8 kg in a year — and no one told me that could be the citalopram." |
| QT interval never checked | Occasional | "I've been on 40 mg for 3 years and never had an ECG." |
| St John's wort taken alongside | Occasional | "I thought herbal couldn't be harmful." |
The St John's wort issue is a recurring pattern: many patients take herbal products as supposedly harmless, without knowing that St John's wort is a potent inducer of liver enzymes and can trigger serotonin syndrome in combination with SSRIs. "Herbal does not mean safe" — this applies particularly in combination with antidepressants.
Stopping citalopram weight gain — what actually helps? Weight gain under citalopram is real — on average 2–5 kg over 6–12 months, in some cases considerably more. The causes are varied: changed eating behaviour, increased appetite for carbohydrates, a slight slowing of metabolism. What genuinely helps: regular exercise (even moderate aerobic training), mindful eating, and keeping a food diary. Anyone who gains substantial weight despite these measures should discuss switching to bupropion or vortioxetine with their doctor — both are considered more weight-neutral.
Stopping citalopram brain zaps — how long do they last? Brain zaps last a few days to several weeks for most patients. They disappear if the taper is slow enough. Anyone who still has them despite following the correct tapering schedule should make the reduction steps even smaller — drops instead of tablets allow doses of 2–3 mg, which is helpful in severe discontinuation symptoms. Brain zaps are not a medical emergency, but if they are very intense or prolonged, the doctor should be informed.
Citalopram in the morning or evening? There is no definitive recommendation — the timing should be guided by the individual side-effect profile. Anyone experiencing fatigue or drowsiness takes citalopram in the evening. Anyone experiencing sleep disturbances or restlessness takes it in the morning. Consistency matters — every day at the same time, to maintain a stable blood level.
How long should citalopram be taken? Guideline recommendations state: at least 6–9 months after complete improvement following a first depressive episode (maintenance therapy). With recurrent episodes (three or more), long-term therapy of two years or more is recommended. Stopping should always be done in consultation with the doctor and after a stable remission period — never on your own initiative and never abruptly.
Citalopram and alcohol — how much is tolerable? There is no absolute prohibition, but alcohol worsens depressive symptoms and enhances the CNS-depressant effect of citalopram. Regular alcohol consumption is fundamentally incompatible with antidepressant therapy. An occasional drink at a social occasion is generally tolerable for most patients — but not a nightly glass to unwind.